{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:59Z","timestamp":1790709419378,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":208,"publisher":"Springer New York","isbn-type":[{"value":"9781493978243","type":"print"},{"value":"9781493978250","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7825-0_4","type":"book-chapter","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T08:44:16Z","timestamp":1527756256000},"page":"41-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cellular Models: HD Patient-Derived Pluripotent Stem Cells"],"prefix":"10.1007","author":[{"given":"Charlene","family":"Geater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia B.","family":"Mattis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971","journal-title":"Cell"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers RH (2004) Huntington\u2019s disease genetics. NeuroRx 1:255","journal-title":"NeuroRx"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R et al (1993) Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 4:387","journal-title":"Nat Genet"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1469-1809.1974.tb01833.x","volume":"37","author":"ED Bird","year":"1974","unstructured":"Bird ED, Caro AJ, Pilling JB (1974) A sex related factor in the inheritance of Huntington\u2019s chorea. Ann Hum Genet 37:255","journal-title":"Ann Hum Genet"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.48.6.530","volume":"48","author":"RH Myers","year":"1985","unstructured":"Myers RH, Sax DS, Schoenfeld M et al (1985) Late onset of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 48:530","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jmg.31.5.377","volume":"31","author":"Y Trottier","year":"1994","unstructured":"Trottier Y, Biancalana V, Mandel J-L (1994) Instability of CAG repeats in Huntington\u2019s disease: relation to parental transmission and age of onset. J Med Genet 31:377","journal-title":"J Med Genet"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B et al (1993) The relationship between trinucleotide (CAG) repeat length. Nat Genet 4:398\u2013403","journal-title":"Nat Genet"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J et\u00a0al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci U S A 101:3498","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrg706","volume":"3","author":"J Gusella","year":"2002","unstructured":"Gusella J, MacDonald M (2002) No post-genetics era in human disease research. Nat Rev Genet 3:72","journal-title":"Nat Rev Genet"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"G Graveland","year":"1985","unstructured":"Graveland G, Williams R, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227:770","journal-title":"Science"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1098\/rstb.1971.0102","volume":"262","author":"JM Kemp","year":"1971","unstructured":"Kemp JM, Powell T (1971) The structure of the caudate nucleus of the cat: light and electron microscopy. Philos Trans R Soc Lond B Biol Sci 262:383","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuroscience.2015.06.033","volume":"301","author":"L Yager","year":"2015","unstructured":"Yager L, Garcia A, Wunsch A et al (2015) The ins and outs of the striatum: role in drug addiction. Neuroscience 301:529","journal-title":"Neuroscience"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"J-P Vonsattel","year":"1985","unstructured":"Vonsattel J-P, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559","journal-title":"J Neuropathol Exp Neurol"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O\u2019Kusky JR et al (1995) Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811","journal-title":"Cell"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis I, Levine MS, Zeitlin S (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet 26:300","journal-title":"Nat Genet"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A et al (1995) Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269:407","journal-title":"Science"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin S, Liu J-P, Chapman DL et al (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat Genet 11:155","journal-title":"Nat Genet"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of Huntingtin. Neuron 89:910","journal-title":"Neuron"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","volume":"107","author":"Z Zheng","year":"2012","unstructured":"Zheng Z, Diamond MI (2012) Huntington disease and the huntingtin protein. Prog Mol Biol Transl Sci 107:189","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","volume":"448","author":"EJ Bennett","year":"2007","unstructured":"Bennett EJ, Shaler TA, Woodman B et al (2007) Global changes to the ubiquitin system in Huntington\u2019s disease. Nature 448:704","journal-title":"Nature"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"16889","DOI":"10.1073\/pnas.1420103111","volume":"111","author":"J Ochaba","year":"2014","unstructured":"Ochaba J, Lukacsovich T, Csikos G et al (2014) Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc Natl Acad Sci U S A 111:16889","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/15384101.2015.1039365","volume":"14","author":"AM Cuervo","year":"2015","unstructured":"Cuervo AM, Zhang S (2015) Selective autophagy and Huntingtin: learning from disease. Cell Cycle 14:1617","journal-title":"Cell Cycle"},{"key":"4_CR23","volume":"6","author":"S Zheng","year":"2010","unstructured":"Zheng S, Clabough EB, Sarkar S et al (2010) Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet 6:e1000838","journal-title":"PLoS Genet"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D et al (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493","journal-title":"Science"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","volume":"220","author":"C Zuccato","year":"2014","unstructured":"Zuccato C, Cattaneo E (2014) Huntington\u2019s disease. Handb Exp Pharmacol 220:357","journal-title":"Handb Exp Pharmacol"},{"key":"4_CR202","first-page":"38","volume":"113","author":"X Zhao","year":"2016","unstructured":"Zhao X, Chen XQ, Han E, Hu Y, Paik P, Ding Z, Overman J, Lau AL, Shahmoradian SH, Chiu W, Thompson LM, Wu C, Mobley WC (2016) TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington\u2019s disease. Proc Natl Acad Sci U S A 113:38","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De-Fraja C et al (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20:3705","journal-title":"J Neurosci"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.38.7.450","volume":"38","author":"LW Ho","year":"2001","unstructured":"Ho LW, Brown R, Maxwell M et al (2001) Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington\u2019s disease. J Med Genet 38:450","journal-title":"J Med Genet"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","volume":"96","author":"BR Leavitt","year":"2006","unstructured":"Leavitt BR, van Raamsdonk JM, Shehadeh J et\u00a0al (2006) Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem 96:1121","journal-title":"J Neurochem"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","volume":"25","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Leavitt BR, van Raamsdonk JM et al (2006) Huntingtin inhibits caspase-3 activation. EMBO J 25:5896","journal-title":"EMBO J"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","volume":"399","author":"VO Ona","year":"1999","unstructured":"Ona VO, Li M, Vonsattel JPG et al (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease. Nature 399:263","journal-title":"Nature"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni J, Ellerby LM (2002) Calpain activation in Huntington\u2019s disease. J Neurosci 22:4842","journal-title":"J Neurosci"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0896-6273(00)80716-3","volume":"22","author":"I Sanchez","year":"1999","unstructured":"Sanchez I, Xu C-J, Juo P et al (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22:623","journal-title":"Neuron"},{"key":"4_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.121","volume":"3","author":"G Cisbani","year":"2012","unstructured":"Cisbani G, Cicchetti F (2012) An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity. Cell Death Dis 3:e382","journal-title":"Cell Death Dis"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M et al (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127","journal-title":"Cell"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","volume":"33","author":"G Liot","year":"2013","unstructured":"Liot G, Zala D, Pla P et al (2013) Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J Neurosci 33:6298","journal-title":"J Neurosci"},{"key":"4_CR36","doi-asserted-by":"crossref","unstructured":"Hu S, Zhao MT, Jahanbani F et al (2016) Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. JCI Insight 1. pii: e85558","DOI":"10.1172\/jci.insight.85558"},{"key":"4_CR37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145","journal-title":"Science"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1472-6483(10)60810-3","volume":"10","author":"Y Verlinsky","year":"2005","unstructured":"Verlinsky Y, Strelchenko N, Kukharenko V et al (2005) Human embryonic stem cell lines with genetic disorders. Reprod Biomed Online 10:105","journal-title":"Reprod Biomed Online"},{"key":"4_CR39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663","journal-title":"Cell"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861","journal-title":"Cell"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917","journal-title":"Science"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2183\/pjab.85.348","volume":"85","author":"N Fusaki","year":"2009","unstructured":"Fusaki N, Ban H, Nishiyama A et al (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85:348","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","volume":"322","author":"M Stadtfeld","year":"2008","unstructured":"Stadtfeld M, Nagaya M, Utikal J et\u00a0al (2008) Induced pluripotent stem cells generated without viral integration. Science 322:945","journal-title":"Science"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1152092","volume":"318","author":"J Hanna","year":"2007","unstructured":"Hanna J, Wernig M, Markoulaki S et al (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920","journal-title":"Science"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nprot.2009.231","volume":"5","author":"K Okita","year":"2010","unstructured":"Okita K, Hong H, Takahashi K et al (2010) Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 5:418","journal-title":"Nat Protoc"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.stem.2011.03.001","volume":"8","author":"F Anokye-Danso","year":"2011","unstructured":"Anokye-Danso F, Trivedi CM, Juhr D et al (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8:376","journal-title":"Cell Stem Cell"},{"key":"4_CR47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","volume":"4","author":"H Zhou","year":"2009","unstructured":"Zhou H, Wu S, Joo JY et al (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381","journal-title":"Cell Stem Cell"},{"key":"4_CR48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nbt.1502","volume":"26","author":"D Huangfu","year":"2008","unstructured":"Huangfu D, Osafune K, Maehr R et al (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269","journal-title":"Nat Biotechnol"},{"key":"4_CR49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrm3584","volume":"14","author":"P Cahan","year":"2013","unstructured":"Cahan P, Daley GQ (2013) Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol 14:357","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4_CR50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature09798","volume":"471","author":"R Lister","year":"2011","unstructured":"Lister R, Pelizzola M, Kida YS et al (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68","journal-title":"Nature"},{"key":"4_CR51","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrn.2016.46","volume":"17","author":"J Mertens","year":"2016","unstructured":"Mertens J, Marchetto MC, Bardy C et al (2016) Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci 17:424","journal-title":"Nat Rev Neurosci"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrm.2016.10","volume":"17","author":"A Trounson","year":"2016","unstructured":"Trounson A, DeWitt ND (2016) Pluripotent stem cells progressing to the clinic. Nat Rev Mol Cell Biol 17:194","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4_CR53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/292154a0","volume":"292","author":"MJ Evans","year":"1981","unstructured":"Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154","journal-title":"Nature"},{"key":"4_CR54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1523\/JNEUROSCI.04-01-00111.1984","volume":"4","author":"CC Ouimet","year":"1984","unstructured":"Ouimet CC, Miller PE, Hemmings HC et al (1984) DARPP-32, a dopamine- and adenosine 3\u2032:5\u2032-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions: III. Immunocytochemical localization. J Neurosci 4:111","journal-title":"J Neurosci"},{"key":"4_CR55","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1523\/JNEUROSCI.19-13-05409.1999","volume":"19","author":"S Ivkovic","year":"1999","unstructured":"Ivkovic S, Ehrlich ME (1999) Expression of the striatal DARPP-32\/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 19:5409","journal-title":"J Neurosci"},{"key":"4_CR56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0306-4522(96)00684-7","volume":"79","author":"S Ivkovic","year":"1997","unstructured":"Ivkovic S, Polonskaia O, Fari\u00f1as I et al (1997) Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro. Neuroscience 79:509","journal-title":"Neuroscience"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1089\/scd.2010.0282","volume":"20","author":"G El-Akabawy","year":"2011","unstructured":"El-Akabawy G, Medina LM, Jeffries A et al (2011) Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the Hedgehog pathway. Stem Cells Dev 20:1873","journal-title":"Stem Cells Dev"},{"key":"4_CR58","doi-asserted-by":"crossref","first-page":"e16707","DOI":"10.1073\/pnas.0808488105","volume":"105","author":"L Aubry","year":"2008","unstructured":"Aubry L, Bugi A, Lefort N et al (2008) Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci U S A 105:e16707","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR59","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","volume":"30","author":"I Jeon","year":"2012","unstructured":"Jeon I, Lee N, Li JY et al (2012) Neuronal properties, in vivo effects, and pathology of a Huntington\u2019s disease patient-derived induced pluripotent stem cells. Stem Cells 30:2054","journal-title":"Stem Cells"},{"key":"4_CR60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1634\/stemcells.2006-0562","volume":"25","author":"AJ Joannides","year":"2007","unstructured":"Joannides AJ, Fiore-Heriche C, Battersby AA et al (2007) A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells 25:731","journal-title":"Stem Cells"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1523\/JNEUROSCI.5128-10.2011","volume":"31","author":"T Danjo","year":"2011","unstructured":"Danjo T, Eiraku M, Muguruma K et al (2011) Subregional specification of embryonic stem cell-derived ventral telencephalic tissues by timed and combinatory treatment with extrinsic signals. J Neurosci 31:1919","journal-title":"J Neurosci"},{"key":"4_CR62","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1193","volume":"2","author":"N Zhang","year":"2010","unstructured":"Zhang N, An MC, Montoro D et al (2010) Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells. PLoS Curr 2:RRN1193","journal-title":"PLoS Curr"},{"key":"4_CR63","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","volume":"10","author":"L Ma","year":"2012","unstructured":"Ma L, Hu B, Liu Y et al (2012) Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 10:455","journal-title":"Cell Stem Cell"},{"key":"4_CR64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1242\/dev.084608","volume":"140","author":"A Delli Carri","year":"2013","unstructured":"Delli Carri A, Onorati M, Lelos MJ et al (2013) Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons. Development 140:301","journal-title":"Development"},{"key":"4_CR65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12015-013-9441-8","volume":"9","author":"A Delli Carri","year":"2013","unstructured":"Delli Carri A, Onorati M, Castiglioni V et al (2013) Human pluripotent stem cell differentiation into authentic striatal projection neurons. Stem Cell Rev 9:461","journal-title":"Stem Cell Rev"},{"key":"4_CR66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers SM, Fasano CA, Papapetrou EP et al (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27:275","journal-title":"Nat Biotechnol"},{"key":"4_CR67","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1242\/dev.117093","volume":"142","author":"C Arber","year":"2015","unstructured":"Arber C, Precious SV, Cambray S et al (2015) Activin A directs striatal projection neuron differentiation of human pluripotent stem cells. Development 142:1375","journal-title":"Development"},{"key":"4_CR68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-016-0092-5","volume":"11","author":"ED Nekrasov","year":"2016","unstructured":"Nekrasov ED, Vigont VA, Klyushnikov SA et al (2016) Manifestation of Huntington\u2019s disease pathology in human induced pluripotent stem cell-derived neurons. Mol Neurodegener 11:27","journal-title":"Mol Neurodegener"},{"key":"4_CR69","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1523\/JNEUROSCI.2986-07.2008","volume":"28","author":"P Arlotta","year":"2008","unstructured":"Arlotta P, Molyneaux BJ, Jabaudon D et al (2008) Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J Neurosci 28:622","journal-title":"J Neurosci"},{"key":"4_CR70","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"The HD iPSC Consortium","year":"2012","unstructured":"The HD iPSC Consortium (2012) Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11:264","journal-title":"Cell Stem Cell"},{"key":"4_CR71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12015-011-9290-2","volume":"8","author":"E Shin","year":"2012","unstructured":"Shin E, Palmer MJ, Li M et al (2012) GABAergic neurons from mouse embryonic stem cells possess functional properties of striatal neurons in vitro, and develop into striatal neurons in vivo in a mouse model of Huntington\u2019s disease. Stem Cell Rev 8:513","journal-title":"Stem Cell Rev"},{"key":"4_CR72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.3175662","volume":"242","author":"SJ Tapscott","year":"1988","unstructured":"Tapscott SJ, Davis RL, Thayer MJ et al (1988) MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242:405","journal-title":"Science"},{"key":"4_CR73","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1523\/JNEUROSCI.1615-07.2007","volume":"27","author":"B Berninger","year":"2007","unstructured":"Berninger B, Costa MR, Koch U et al (2007) Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J Neurosci 27:8654","journal-title":"J Neurosci"},{"key":"4_CR74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000373","volume":"8","author":"C Heinrich","year":"2010","unstructured":"Heinrich C, Blum R, Gasc\u00f3n S et al (2010) Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol 8:e1000373","journal-title":"PLoS Biol"},{"key":"4_CR75","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y et al (2013) Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78:785","journal-title":"Neuron"},{"key":"4_CR76","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP et al (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035","journal-title":"Nature"},{"key":"4_CR77","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4161\/cc.10.19.17584","volume":"10","author":"U Pfisterer","year":"2011","unstructured":"Pfisterer U, Wood J, Nihlberg K et al (2011) Efficient induction of functional neurons from adult human fibroblasts. Cell Cycle 10:3311","journal-title":"Cell Cycle"},{"key":"4_CR78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang ZP, Yang N, Vierbuchen T et al (2011) Induction of human neuronal cells by defined transcription factors. Nature 476:220","journal-title":"Nature"},{"key":"4_CR79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneumeth.2013.03.020","volume":"216","author":"J Davila","year":"2013","unstructured":"Davila J, Chanda S, Ang CE et al (2013) Acute reduction in oxygen tension enhances the induction of neurons from human fibroblasts. J Neurosci Methods 216:104","journal-title":"J Neurosci Methods"},{"key":"4_CR80","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature10323","volume":"476","author":"AS Yoo","year":"2011","unstructured":"Yoo AS, Sun AX, Li L et al (2011) MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476:228","journal-title":"Nature"},{"key":"4_CR81","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuron.2014.10.016","volume":"84","author":"MB Victor","year":"2014","unstructured":"Victor MB, Richner M, TO H et al (2014) Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron 84:311","journal-title":"Neuron"},{"key":"4_CR82","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1073\/pnas.1611473114","volume":"114","author":"A Faedo","year":"2017","unstructured":"Faedo A, Laporta A, Segnali A et al (2017) Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1. Proc Natl Acad Sci U S A 114:1234","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4_CR83","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","volume":"24","author":"VB Mattis","year":"2015","unstructured":"Mattis VB, Tom C, Akimov S et al (2015) HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Hum Mol Genet 24(11):3257\u20133271","journal-title":"Hum Mol Genet"},{"key":"4_CR84","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park IH, Arora N, Huo H et al (2008) Disease-specific induced pluripotent stem cells. Cell 134:877","journal-title":"Cell"},{"key":"4_CR85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2011.12.042","volume":"46","author":"S Camnasio","year":"2012","unstructured":"Camnasio S, Delli Carri A, Lombardo A et al (2012) The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington\u2019s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis 46:41","journal-title":"Neurobiol Dis"},{"key":"4_CR86","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/humrep\/dei345","volume":"21","author":"I Mateizel","year":"2006","unstructured":"Mateizel I, De Temmerman N, Ullmann U et al (2006) Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21:503","journal-title":"Hum Reprod"},{"key":"4_CR87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1472-6483(10)60053-3","volume":"19","author":"JC Niclis","year":"2009","unstructured":"Niclis JC, Trounson A, Dottori M et al (2009) Human embryonic stem cell models of Huntington disease. Reprod Biomed Online 19:106","journal-title":"Reprod Biomed Online"},{"key":"4_CR88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126860","volume":"10","author":"L Jacquet","year":"2015","unstructured":"Jacquet L, Neueder A, F\u00f6ldes G et al (2015) Three Huntington\u2019s disease specific mutation-carrying human embryonic stem cell lines have stable number of CAG repeats upon in vitro differentiation into cardiomyocytes. PLoS One 10:e0126860","journal-title":"PLoS One"},{"key":"4_CR89","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/scd.2010.0120","volume":"20","author":"CK Bradley","year":"2010","unstructured":"Bradley CK, Scott HA, Chami O et al (2010) Derivation of Huntington\u2019s disease-affected human embryonic stem cell lines. Stem Cells Dev 20:495","journal-title":"Stem Cells Dev"},{"key":"4_CR90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.scr.2016.02.007","volume":"16","author":"B Dumevska","year":"2016","unstructured":"Dumevska B, McKernan R, Goel D et al (2016) Derivation of Huntington disease affected Genea017 human embryonic stem cell line. Stem Cell Res 16:493","journal-title":"Stem Cell Res"},{"key":"4_CR91","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.scr.2016.02.006","volume":"16","author":"B Dumevska","year":"2016","unstructured":"Dumevska B, Main H, McKernan R et al (2016) Derivation of Huntington disease affected Genea018 human embryonic stem cell line. Stem Cell Res 16:423","journal-title":"Stem Cell Res"},{"key":"4_CR92","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.scr.2016.02.009","volume":"16","author":"B Dumevska","year":"2016","unstructured":"Dumevska B, Peura T, McKernan R et al (2016) Derivation of Huntington disease affected Genea020 human embryonic stem cell line. Stem Cell Res 16:430","journal-title":"Stem Cell Res"},{"key":"4_CR93","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.scr.2016.02.021","volume":"16","author":"B Dumevska","year":"2016","unstructured":"Dumevska B, Chami O, McKernan R et al (2016) Derivation of Huntington disease affected Genea046 human embryonic stem cell line. Stem Cell Res 16:446","journal-title":"Stem Cell Res"},{"key":"4_CR94","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.scr.2016.02.013","volume":"16","author":"B Dumevska","year":"2016","unstructured":"Dumevska B, McKernan R, Hu J et\u00a0al (2016) Derivation of Huntington disease affected Genea089 human embryonic stem cell line. Stem Cell Res 16:434","journal-title":"Stem Cell Res"},{"key":"4_CR95","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.scr.2016.02.024","volume":"16","author":"B Dumevska","year":"2016","unstructured":"Dumevska B, Schaft J, McKernan R et al (2016) Derivation of Huntington disease affected Genea090 human embryonic stem cell line. Stem Cell Res 16:519","journal-title":"Stem Cell Res"},{"key":"4_CR96","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.scr.2016.02.022","volume":"16","author":"B Dumevska","year":"2016","unstructured":"Dumevska B, Schaft J, McKernan R et al (2016) Derivation of Huntington disease affected Genea091 human embryonic stem cell line. Stem Cell Res 16:449","journal-title":"Stem Cell Res"},{"key":"4_CR97","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","volume":"18","author":"M Swami","year":"2009","unstructured":"Swami M, Hendricks AE, Gillis T et al (2009) Somatic expansion of the Huntington\u2019s disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum Mol Genet 18:3039","journal-title":"Hum Mol Genet"},{"key":"4_CR98","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.2858129","volume":"227","author":"JT Greenamyre","year":"1985","unstructured":"Greenamyre JT, Penney JB, Young AB et al (1985) Alterations in l-glutamate binding in Alzheimer\u2019s and Huntington\u2019s diseases. Science 227:1496","journal-title":"Science"},{"key":"4_CR99","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","volume":"322","author":"I Bezprozvanny","year":"2004","unstructured":"Bezprozvanny I, Hayden MR (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun 322:1310","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR100","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1046\/j.0953-816x.2001.01783.x","volume":"14","author":"C Cepeda","year":"2001","unstructured":"Cepeda C, Itri JN, Flores-Hern\u00e1ndez J et\u00a0al (2001) Differential sensitivity of medium-and large-sized striatal neurons to NMDA but not kainate receptor activation in the rat. Eur J Neurosci 14:1577","journal-title":"Eur J Neurosci"},{"key":"4_CR101","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet GA, Sapp E, Chase K et al (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease. J Neurosci 21:9412","journal-title":"J Neurosci"},{"key":"4_CR102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","volume":"25","author":"MM Zeron","year":"2004","unstructured":"Zeron MM, Fernandes HB, Krebs C et al (2004) Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington\u2019s disease. Mol Cell Neurosci 25:469","journal-title":"Mol Cell Neurosci"},{"key":"4_CR103","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V, Hassig R et al (2009) Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 65:276","journal-title":"Ann Neurol"},{"key":"4_CR104","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/hmg\/ddq456","volume":"20","author":"A Seriola","year":"2011","unstructured":"Seriola A, Spits C, Simard JP et al (2011) Huntington\u2019s and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation. Hum Mol Genet 20:176","journal-title":"Hum Mol Genet"},{"key":"4_CR105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","volume":"11","author":"MC An","year":"2012","unstructured":"An MC, Zhang N, Scott G et al (2012) Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11:253","journal-title":"Cell Stem Cell"},{"key":"4_CR106","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20111495","volume":"446","author":"JI Chae","year":"2012","unstructured":"Chae JI, Kim DW, Lee N et al (2012) Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington\u2019s disease patient. Biochem J 446:359","journal-title":"Biochem J"},{"key":"4_CR107","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/cn500100r","volume":"5","author":"BS Khakh","year":"2014","unstructured":"Khakh BS, Sofroniew MV (2014) Astrocytes and Huntington\u2019s disease. ACS Chem Neurosci 5:494","journal-title":"ACS Chem Neurosci"},{"key":"4_CR108","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1021\/pr500649m","volume":"13","author":"LR McQuade","year":"2014","unstructured":"McQuade LR, Balachandran A, Scott HA et al (2014) Proteomics of Huntington\u2019s disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances. J Proteome Res 13:5648","journal-title":"J Proteome Res"},{"key":"4_CR109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118307","volume":"10","author":"I Garitaonandia","year":"2015","unstructured":"Garitaonandia I, Amir H, Boscolo FS et al (2015) Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions. PLoS One 10:e0118307","journal-title":"PLoS One"},{"key":"4_CR110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","volume":"90","author":"E Scherzinger","year":"1997","unstructured":"Scherzinger E, Lurz R, Turmaine M et al (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549","journal-title":"Cell"},{"key":"4_CR111","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1093\/hmg\/dds216","volume":"21","author":"M Feyeux","year":"2012","unstructured":"Feyeux M, Bourgois-Rocha F, Redfern A et al (2012) Early transcriptional changes linked to naturally occurring Huntington\u2019s disease mutations in neural derivatives of human embryonic stem cells. Hum Mol Genet 21:3883","journal-title":"Hum Mol Genet"},{"key":"4_CR112","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.stemcr.2015.11.005","volume":"5","author":"KL Ring","year":"2015","unstructured":"Ring KL, An MC, Zhang N et al (2015) Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human Huntington\u2019s disease neural stem cells. Stem Cell Reports 5:1023","journal-title":"Stem Cell Reports"},{"key":"4_CR113","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/stem.788","volume":"30","author":"MC Puri","year":"2012","unstructured":"Puri MC, Nagy A (2012) Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells 30:10","journal-title":"Stem Cells"},{"key":"4_CR114","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/mt.2011.41","volume":"19","author":"KH Narsinh","year":"2011","unstructured":"Narsinh KH, Plews J, Wu JC (2011) Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol Ther 19:635","journal-title":"Mol Ther"},{"key":"4_CR115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt.1667","volume":"28","author":"JM Polo","year":"2010","unstructured":"Polo JM, Liu S, Figueroa ME et al (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28:848","journal-title":"Nat Biotechnol"},{"key":"4_CR116","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim K, Doi A, Wen B et al (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467:285","journal-title":"Nature"},{"key":"4_CR117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004175","volume":"4","author":"A Urbach","year":"2009","unstructured":"Urbach A, Benvenisty N (2009) Studying early lethality of 45,XO (Turner\u2019s syndrome) embryos using human embryonic stem cells. PLoS One 4:e4175","journal-title":"PLoS One"},{"key":"4_CR118","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.stem.2011.03.003","volume":"8","author":"AD Panopoulos","year":"2011","unstructured":"Panopoulos AD, Ruiz S, Izpisua Belmonte JC (2011) iPSCs: induced back to controversy. Cell Stem Cell 8:347","journal-title":"Cell Stem Cell"},{"key":"4_CR119","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nmeth.1323","volume":"6","author":"K Yusa","year":"2009","unstructured":"Yusa K, Rad R, Takeda J et\u00a0al (2009) Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6:363","journal-title":"Nat Methods"},{"key":"4_CR120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, Manos PD, Ahfeldt T et al (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618","journal-title":"Cell Stem Cell"},{"key":"4_CR121","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.cell.2013.05.006","volume":"153","author":"M Tachibana","year":"2013","unstructured":"Tachibana M, Amato P, Sparman M et al (2013) Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153:1228","journal-title":"Cell"},{"key":"4_CR122","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1073\/pnas.38.5.455","volume":"38","author":"R Briggs","year":"1952","unstructured":"Briggs R, King TJ (1952) Transplantation of living nuclei from blastula cells into enucleated frogs\u2019 eggs. Proc Natl Acad Sci U S A 38:455","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR123","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nprot.2013.090","volume":"8","author":"K Hayashi","year":"2013","unstructured":"Hayashi K, Saitou M (2013) Generation of eggs from mouse embryonic stem cells and induced pluripotent stem cells. Nat Protoc 8:1513","journal-title":"Nat Protoc"},{"key":"4_CR124","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2015.10.001","volume":"1656","author":"VB Mattis","year":"2017","unstructured":"Mattis VB, Svendsen CN (2017) Modeling Huntington\u2032s disease with patient-derived neurons. Brain Res 1656:76\u201387","journal-title":"Brain Res"},{"key":"4_CR125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","volume":"471","author":"A Gore","year":"2011","unstructured":"Gore A, Li Z, Fung HL et al (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63","journal-title":"Nature"},{"key":"4_CR126","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","volume":"186","author":"M Christian","year":"2010","unstructured":"Christian M, Cermak T, Doyle EL et al (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757","journal-title":"Genetics"},{"key":"4_CR127","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","volume":"93","author":"YG Kim","year":"1996","unstructured":"Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 93:1156","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nbt.2508","volume":"31","author":"W Jiang","year":"2013","unstructured":"Jiang W, Bikard D, Cox D et al (2013) RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31:233","journal-title":"Nat Biotechnol"},{"key":"4_CR129","doi-asserted-by":"publisher","unstructured":"An MC, O\u2019Brien RN, Zhang N et al (2014) Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR\/Cas9 system. PLoS Curr 6. \nhttps:\/\/doi.org\/10.1371\/currents.hd.0242d2e7ad72225efa72f6964589369a","DOI":"10.1371\/currents.hd.0242d2e7ad72225efa72f6964589369a"},{"issue":"2","key":"4_CR203","doi-asserted-by":"crossref","first-page":"dev156844","DOI":"10.1242\/dev.156844","volume":"145","author":"Albert Ruzo","year":"2018","unstructured":"Ruzo A, Croft GF, Metzger JJ, Galgoczi S, Gerber LJ, Pellegrini C, Wang H Jr, Fenner M, Tse S, Marks A, Nchako C, Brivanlou AH (2018) Chromosomal instability during neurogenesis in Huntington\u2019s disease. Development 145:2","journal-title":"Development"},{"key":"4_CR130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH et al (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78:690","journal-title":"Neurology"},{"key":"4_CR131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.1783","volume":"29","author":"GL Boulting","year":"2011","unstructured":"Boulting GL, Kiskinis E, Croft GF et al (2011) A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 29:279","journal-title":"Nat Biotechnol"},{"key":"4_CR132","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","volume":"107","author":"B-Y Hu","year":"2010","unstructured":"Hu B-Y, Weick JP, Yu J et\u00a0al (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 107:4335","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR204","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3389\/fnins.2017.00736","volume":"11","author":"S Naphade","year":"2018","unstructured":"Naphade S, Embusch A, Madushani KL, Ring KL, Ellerby LM (2018) Altered expression of matrix metalloproteinases and their endogenous inhibitors in a human isogenic stem cell model of Huntington\u2019s disease. Front Neurosci 11:736","journal-title":"Front Neurosci"},{"key":"4_CR133","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-5-17","volume":"5","author":"TA Juopperi","year":"2012","unstructured":"Juopperi TA, Kim WR, Chiang CH et al (2012) Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington\u2019s disease patient cells. Mol Brain 5:17","journal-title":"Mol Brain"},{"key":"4_CR134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fncel.2013.00037","volume":"7","author":"JC Niclis","year":"2013","unstructured":"Niclis JC, Pinar A, Haynes JM et al (2013) Characterization of forebrain neurons derived from late-onset Huntington\u2019s disease human embryonic stem cell lines. Front Cell Neurosci 7:37","journal-title":"Front Cell Neurosci"},{"key":"4_CR135","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/edee8dfa-6b2a-44f4-866a-098f186e27f0","volume":"8","author":"GD Nguyen","year":"2013","unstructured":"Nguyen GD, Gokhan S, Molero AE et al (2013) Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis. PLoS One 8:e64368","journal-title":"PLoS One"},{"key":"4_CR205","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1073\/pnas.1715865115","volume":"115","author":"P Conforti","year":"2018","unstructured":"Conforti P, Besusso D, Bocchi VD, Faedo A, Cesana E, Rossetti G, Ranzani V, Svendsen CN, Thompson LM, Toselli M, Biella G, Pagani M, Cattaneo E (2018) Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes. Proc Natl Acad Sci U S A. 115:4","journal-title":"Proc Natl Acad Sci U S A."},{"key":"4_CR136","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2990.1995.tb01024.x","volume":"21","author":"M Jackson","year":"1995","unstructured":"Jackson M, Gentleman S, Lennox G et al (1995) The cortical neuritic pathology of Huntington\u2019s disease. Neuropathol Appl Neurobiol 21:18","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4_CR137","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","volume":"25","author":"MJ Mihm","year":"2007","unstructured":"Mihm MJ, Amann DM, Schanbacher BL et al (2007) Cardiac dysfunction in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 25:297","journal-title":"Neurobiol Dis"},{"key":"4_CR138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2011.05.006","volume":"44","author":"JM Burg van der","year":"2011","unstructured":"van der Burg JM, Winqvist A, Aziz NA et al (2011) Gastrointestinal dysfunction contributes to weight loss in Huntington\u2019s disease mice. Neurobiol Dis 44:1","journal-title":"Neurobiol Dis"},{"key":"4_CR139","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/nprot.2012.116","volume":"7","author":"Y Shi","year":"2012","unstructured":"Shi Y, Kirwan P, Livesey FJ (2012) Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc 7:1836","journal-title":"Nat Protoc"},{"key":"4_CR140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","volume":"470","author":"JR Spence","year":"2011","unstructured":"Spence JR, Mayhew CN, Rankin SA et al (2011) Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470:105","journal-title":"Nature"},{"key":"4_CR141","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","volume":"111","author":"CL Mummery","year":"2012","unstructured":"Mummery CL, Zhang J, Ng ES et al (2012) Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111:344","journal-title":"Circ Res"},{"key":"4_CR142","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G Egger","year":"2004","unstructured":"Egger G, Liang G, Aparicio A et al (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457","journal-title":"Nature"},{"key":"4_CR143","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jmcb\/mjs007","volume":"4","author":"O Bar-Nur","year":"2012","unstructured":"Bar-Nur O, Caspi I, Benvenisty N (2012) Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. J Mol Cell Biol 4:180","journal-title":"J Mol Cell Biol"},{"key":"4_CR206","doi-asserted-by":"publisher","unstructured":"Victor MB, Richner M, Olsen HE, Lee SW, Monteys AM, Ma C, Huh CJ, Zhang B, Davidson BL, Yang XW, Yoo AS (2018) Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat Neurosci. \nhttps:\/\/doi.org\/10.1038\/s41593-018-0075-7","DOI":"10.1038\/s41593-018-0075-7"},{"key":"4_CR144","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP et al (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1:249","journal-title":"Psychiatry Res"},{"key":"4_CR145","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW et al (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979","journal-title":"Science"},{"key":"4_CR146","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262","journal-title":"Cell"},{"issue":"20","key":"4_CR147","first-page":"4566","volume":"25","author":"JW Shin","year":"2016","unstructured":"Shin JW, Kim KH, Chao MJ et al (2016) Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9. Hum Mol Genet 25(20):4566\u20134576","journal-title":"Hum Mol Genet"},{"key":"4_CR148","doi-asserted-by":"crossref","first-page":"768391","DOI":"10.1155\/2014\/768391","volume":"2014","author":"S Raab","year":"2014","unstructured":"Raab S, Klingenstein M, Liebau S et al (2014) A comparative view on human somatic cell sources for iPSC generation. Stem Cells Int 2014:768391","journal-title":"Stem Cells Int"},{"key":"4_CR149","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.5966\/sctm.2014-0076","volume":"3","author":"D Sareen","year":"2014","unstructured":"Sareen D, Saghizadeh M, Ornelas L et al (2014) Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. Stem Cells Transl Med 3:1002","journal-title":"Stem Cells Transl Med"},{"key":"4_CR150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/em.20004","volume":"43","author":"KA Hill","year":"2004","unstructured":"Hill KA, Buettner VL, Halangoda A et al (2004) Spontaneous mutation in Big Blue mice from fetus to old age: tissue-specific time courses of mutation frequency but similar mutation types. Environ Mol Mutagen 43:110","journal-title":"Environ Mol Mutagen"},{"key":"4_CR151","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.1607794113","volume":"113","author":"ML Hoang","year":"2016","unstructured":"Hoang ML, Kinde I, Tomasetti C et al (2016) Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing. Proc Natl Acad Sci U S A 113:9846","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR152","doi-asserted-by":"publisher","unstructured":"El Hokayem J, Cukier HN, Dykxhoorn DM (2016) Blood derived induced pluripotent stem cells (iPSCs): benefits, challenges and the road ahead. J Alzheimers Dis Parkinsonism 6. \nhttps:\/\/doi.org\/10.4172\/2161-0460.1000275","DOI":"10.4172\/2161-0460.1000275"},{"key":"4_CR153","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.stem.2016.02.005","volume":"18","author":"E Kang","year":"2016","unstructured":"Kang E, Wang X, Tippner-Hedges R et al (2016) Age-related accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs. Cell Stem Cell 18:625","journal-title":"Cell Stem Cell"},{"key":"4_CR154","doi-asserted-by":"crossref","first-page":"201801","DOI":"10.1103\/PhysRevLett.96.201801","volume":"96","author":"A Abulencia","year":"2006","unstructured":"Abulencia A, Acosta D, Adelman J et\u00a0al (2006) Direct search for Dirac magnetic monopoles in pp collisions at square root s = 1.96 TeV. Phys Rev Lett 96:201801","journal-title":"Phys Rev Lett"},{"key":"4_CR155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.20207","volume":"56","author":"H Seo","year":"2004","unstructured":"Seo H, Sonntag KC, Isacson O (2004) Generalized brain and skin proteasome inhibition in Huntington\u2019s disease. Ann Neurol 56:319","journal-title":"Ann Neurol"},{"key":"4_CR156","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","volume":"17","author":"K Varani","year":"2003","unstructured":"Varani K, Abbracchio MP, Cannella M et al (2003) Aberrant A2A receptor function in peripheral blood cells in Huntington\u2019s disease. FASEB J 17:2148","journal-title":"FASEB J"},{"key":"4_CR157","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.expneurol.2016.05.002","volume":"282","author":"SV Precious","year":"2016","unstructured":"Precious SV, Kelly CM, Reddington AE et al (2016) FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiation. Exp Neurol 282:9","journal-title":"Exp Neurol"},{"key":"4_CR158","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuroscience.2016.07.022","volume":"333","author":"M Straccia","year":"2016","unstructured":"Straccia M, Carrere J, Rosser AE et al (2016) Human t-DARPP is induced during striatal development. Neuroscience 333:320","journal-title":"Neuroscience"},{"key":"4_CR159","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.stem.2010.07.017","volume":"7","author":"Y Mayshar","year":"2010","unstructured":"Mayshar Y, Ben-David U, Lavon N et al (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7:521","journal-title":"Cell Stem Cell"},{"key":"4_CR160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt.1835","volume":"29","author":"SM Taapken","year":"2011","unstructured":"Taapken SM, Nisler BS, Newton MA et al (2011) Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol 29:313","journal-title":"Nat Biotechnol"},{"key":"4_CR161","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nbt.1615","volume":"28","author":"E N\u00e4rv\u00e4","year":"2010","unstructured":"N\u00e4rv\u00e4 E, Autio R, Rahkonen N et al (2010) High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 28:371","journal-title":"Nat Biotechnol"},{"key":"4_CR162","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nbt.2051","volume":"29","author":"K Amps","year":"2011","unstructured":"Amps K, Andrews PW, Anyfantis G et al (2011) Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 29:1132","journal-title":"Nat Biotechnol"},{"key":"4_CR163","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ng1631","volume":"37","author":"A Maitra","year":"2005","unstructured":"Maitra A, Arking DE, Shivapurkar N et al (2005) Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099","journal-title":"Nat Genet"},{"key":"4_CR164","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nmeth.1580","volume":"8","author":"FJ M\u00fcller","year":"2011","unstructured":"M\u00fcller FJ, Schuldt BM, Williams R et al (2011) A bioinformatic assay for pluripotency in human cells. Nat Methods 8:315","journal-title":"Nat Methods"},{"key":"4_CR165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2005.02.018","volume":"121","author":"K Hochedlinger","year":"2005","unstructured":"Hochedlinger K, Yamada Y, Beard C et al (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121:465","journal-title":"Cell"},{"key":"4_CR166","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ijc.23225","volume":"122","author":"ET Park","year":"2008","unstructured":"Park ET, Gum JR, Kakar S et al (2008) Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer 122:1253","journal-title":"Int J Cancer"},{"key":"4_CR167","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.cr.7290271","volume":"15","author":"AM Ghaleb","year":"2005","unstructured":"Ghaleb AM, Nandan MO, Chanchevalap S et al (2005) Kr\u00fcppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15:92","journal-title":"Cell Res"},{"key":"4_CR168","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000092507","volume":"1","author":"F Kuttler","year":"2006","unstructured":"Kuttler F, Mai S (2006) c-Myc, genomic instability and disease. Genome Dyn 1:171","journal-title":"Genome Dyn"},{"key":"4_CR169","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313","journal-title":"Nature"},{"key":"4_CR170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2010.06.003","volume":"7","author":"T Seki","year":"2010","unstructured":"Seki T, Yuasa S, Oda M et al (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7:11","journal-title":"Cell Stem Cell"},{"key":"4_CR171","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"J Yu","year":"2009","unstructured":"Yu J, Hu K, Smuga-Otto K et al (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797","journal-title":"Science"},{"key":"4_CR172","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini L, Sathasivam K, Mahal A et al (1997) Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat Genet 15:197","journal-title":"Nat Genet"},{"key":"4_CR173","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1073\/pnas.0800048105","volume":"105","author":"R Gonitel","year":"2008","unstructured":"Gonitel R, Moffitt H, Sathasivam K et al (2008) DNA instability in postmitotic neurons. Proc Natl Acad Sci U S A 105:3467","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR174","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/hmg\/ddm054","volume":"16","author":"PF Shelbourne","year":"2007","unstructured":"Shelbourne PF, Keller-McGandy C, Bi WL et al (2007) Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Hum Mol Genet 16:1133","journal-title":"Hum Mol Genet"},{"key":"4_CR175","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.scr.2013.08.010","volume":"11","author":"I Jonson","year":"2013","unstructured":"Jonson I, Ougland R, Klungland A et al (2013) Oxidative stress causes DNA triplet expansion in Huntington\u2019s disease mouse embryonic stem cells. Stem Cell Res 11:1264","journal-title":"Stem Cell Res"},{"key":"4_CR176","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt1383","volume":"26","author":"K Osafune","year":"2008","unstructured":"Osafune K, Caron L, Borowiak M et al (2008) Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26:313","journal-title":"Nat Biotechnol"},{"key":"4_CR177","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller JD, Ganat YM, Kishinevsky S et al (2013) Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13:691","journal-title":"Cell Stem Cell"},{"key":"4_CR178","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/brain\/awq280","volume":"134","author":"PC Nopoulos","year":"2011","unstructured":"Nopoulos PC, Aylward EH, Ross CA et al (2011) Smaller intracranial volume in prodromal Huntington\u2019s disease: evidence for abnormal neurodevelopment. Brain 134:137","journal-title":"Brain"},{"key":"4_CR179","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuroimage.2011.08.062","volume":"59","author":"I Blockx","year":"2012","unstructured":"Blockx I, De Groof G, Verhoye M et al (2012) Microstructural changes observed with DKI in a transgenic Huntington rat model: evidence for abnormal neurodevelopment. Neuroimage 59:957","journal-title":"Neuroimage"},{"key":"4_CR180","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1073\/pnas.1603871113","volume":"113","author":"AE Molero","year":"2016","unstructured":"Molero AE, Arteaga-Bracho EE, Chen CH et al (2016) Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington\u2019s disease. Proc Natl Acad Sci U S A 113:5736","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR181","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","volume":"123","author":"X Guo","year":"2013","unstructured":"Guo X, Disatnik MH, Monbureau M et al (2013) Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration. J Clin Invest 123:5371","journal-title":"J Clin Invest"},{"key":"4_CR182","volume":"6","author":"XH Lu","year":"2014","unstructured":"Lu XH, Mattis VB, Wang N et al (2014) Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease. Sci Transl Med 6:268ra178","journal-title":"Sci Transl Med"},{"key":"4_CR183","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/stem.1430","volume":"31","author":"J Charbord","year":"2013","unstructured":"Charbord J, Poydenot P, Bonnefond C et al (2013) High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells 31:1816","journal-title":"Stem Cells"},{"key":"4_CR184","doi-asserted-by":"crossref","first-page":"5934782","DOI":"10.1155\/2016\/5934782","volume":"2016","author":"AJ Orqueda","year":"2016","unstructured":"Orqueda AJ, Gim\u00e9nez CA, Pereyra-Bonnet F (2016) iPSCs: a minireview from bench to bed, including organoids and the CRISPR system. Stem Cells Int 2016:5934782","journal-title":"Stem Cells Int"},{"key":"4_CR185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1242\/dmm.002451","volume":"2","author":"DE Ehrnhoefer","year":"2009","unstructured":"Ehrnhoefer DE, Butland SL, Pouladi MA et al (2009) Mouse models of Huntington disease: variations on a theme. Dis Model Mech 2:123","journal-title":"Dis Model Mech"},{"key":"4_CR186","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","volume":"30","author":"ES Lippmann","year":"2012","unstructured":"Lippmann ES, Azarin SM, Kay JE et al (2012) Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol 30:783","journal-title":"Nat Biotechnol"},{"key":"4_CR207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1126\/sciadv.1701679","volume":"3","author":"T Qian","year":"2017","unstructured":"Qian T, Maguire SE, Canfield SG, Bao X, Olson WR, Shusta EV, Palecek SP (2017) Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells. Sci Adv. 3:11","journal-title":"Sci Adv."},{"key":"4_CR187","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fncel.2016.00215","volume":"10","author":"A Chandrasekaran","year":"2016","unstructured":"Chandrasekaran A, Avci HX, Leist M et al (2016) Astrocyte differentiation of human pluripotent stem cells: new tools for neurological disorder research. Front Cell Neurosci 10:215","journal-title":"Front Cell Neurosci"},{"key":"4_CR188","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/acn3.214","volume":"2","author":"HD Rosas","year":"2015","unstructured":"Rosas HD, Doros G, Bhasin S et al (2015) A systems-level \u201cmisunderstanding\u201d: the plasma metabolome in Huntington\u2019s disease. Ann Clin Transl Neurol 2:756","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"4_CR189","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbrc.2016.09.065","volume":"483","author":"G Liot","year":"2016","unstructured":"Liot G, Valette J, P\u00e9pin J et\u00a0al (2016) Energy defects in Huntington\u2019s disease: why \u201cin vivo\u201d evidence matters. Biochem Biophys Res Commun 483(4):1084\u20131095","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR192","volume":"7","author":"JA Umbach","year":"2012","unstructured":"Umbach JA, Adams KL, Gundersen CB et al (2012) Functional neuromuscular junctions formed by embryonic stem cell-derived motor neurons. PLoS One 7:e36049","journal-title":"PLoS One"},{"key":"4_CR208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.stem.2017.07.007","volume":"21","author":"Y Xiang","year":"2017","unstructured":"Xiang Y, Tanaka Y, Patterson B, Kang YJ, Govindaiah G, Roselaar N, Cakir B, Kim KY, Lombroso AP, Hwang SM, Zhong M, Stanley EG, Elefanty AG, Naegele JR, Lee SH, Weissman SM, Park IH (2017) Fusion of regionally specified hPSC-derived organoids models human brain development and interneuron migration. Cell Stem Cell 21:3","journal-title":"Cell Stem Cell"},{"key":"4_CR193","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-62703-640-5_13","volume":"1078","author":"A Darbinyan","year":"2013","unstructured":"Darbinyan A, Pozniak P, Darbinian N et al (2013) Compartmentalized neuronal cultures. Methods Mol Biol 1078:147","journal-title":"Methods Mol Biol"},{"key":"4_CR194","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia SN, Ingber DE (2014) Microfluidic organs-on-chips. Nat Biotechnol 32:760","journal-title":"Nat Biotechnol"},{"key":"4_CR195","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/stem.514","volume":"28","author":"JP Weick","year":"2010","unstructured":"Weick JP, Johnson MA, Skroch SP et al (2010) Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 28:2008","journal-title":"Stem Cells"},{"key":"4_CR196","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA et al (2013) Cerebral organoids model human brain development and microcephaly. Nature 501:373","journal-title":"Nature"},{"key":"4_CR197","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","volume":"18","author":"A Fatehullah","year":"2016","unstructured":"Fatehullah A, Tan SH, Barker N (2016) Organoids as an in vitro model of human development and disease. Nat Cell Biol 18:246","journal-title":"Nat Cell Biol"},{"key":"4_CR198","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pa\u015fca","year":"2015","unstructured":"Pa\u015fca AM, Sloan SA, Clarke LE et al (2015) Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods 12:671","journal-title":"Nat Methods"},{"key":"4_CR199","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti A, Benner C, Kerman BE et al (2014) Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci 17:513","journal-title":"Nat Neurosci"},{"key":"4_CR200","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","volume":"85","author":"B Huang","year":"2015","unstructured":"Huang B, Wei W, Wang G et al (2015) Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes. Neuron 85:1212","journal-title":"Neuron"},{"issue":"6","key":"4_CR190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","volume":"17","author":"J Mertens","year":"2015","unstructured":"Mertens J, Paquola AC, Ku M et al (2015) Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17(6):705\u2013718","journal-title":"Cell Stem Cell"},{"key":"4_CR191","doi-asserted-by":"publisher","unstructured":"Huh CJ, Zhang B, Victor MB et al (2016) Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts. Elife 5. \nhttps:\/\/doi.org\/10.7554\/eLife.18648","DOI":"10.7554\/eLife.18648"},{"key":"4_CR201","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinte.1995.00430070125014","volume":"155","author":"S Bran","year":"1995","unstructured":"Bran S, Murray WA, Hirsch IB et al (1995) Long QT syndrome during high-dose cisapride. Arch Intern Med 155:765","journal-title":"Arch Intern Med"}],"container-title":["Methods in Molecular Biology","Huntington\u2019s Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7825-0_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T09:01:09Z","timestamp":1532595669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7825-0_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978243","9781493978250"],"references-count":208,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7825-0_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}